Orthopedic Business Review
Will Kurtz, M.D.
The Orthopedic Business Review discusses business topics at the intersection of orthopedics and technology.
Musculoskeletal Digital Therapeutic Companies
Are DTx MSK companies (Hinge Health) successful because of their technology, their business strategy, or their lack of regulations?
Value Creation vs. Value Capture in Orthopedics
This OBR article looks at commoditization, market forces, value creation and value capture to explain why much of healthcare delivers a poor patient experience.
Why orthopedic implant companies struggle with developing patient engagement software
The differences between selling orthopedic implants and software makes it difficult for orthopedic implant companies to succeed in developing software.
Transitioning from Scarcity to Abundance in Orthopedics
Old monopolies (J.D. Rockefeller) aggregated oil refineries (supply side) and squeezed the customers (demand side). Today’s tech monopolies aggregate customers (demand side) and squeeze advertisers (supply side). Healthcare systems are transitioning from supply sided monopolies (regulatory capture and large health systems) to demand sided monopolies (delighting patients with extra services).
Direct to Employer Contracting in Orthopedics
Direct to employer contracting involves large orthopedic groups contracting with large companies to provide MSK services without going through a third party administrator (TPA).
